ARK Genomic Revolution ETF (ARKG)Health | Exchange Traded Fund | Cboe US
49.24 USD
+0.96
(1.988%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 3:59 a.m. EDT
The ARK Genomic Revolution ETF is currently caught in a tug-of-war between its explosive long-term recovery and the heavy overhead resistance created by institutional selling. Fundamentally, the story is compelling: the asset has erased nearly half of its losses since the 2022 trough, delivering a +55% gain over the last nine years. The most recent annual return was a strong +27%, proving the business quality has stabilized and the market has begun to re-rate the portfolio. However, the technical picture is messy. The price is hovering just below the $50 psychological barrier, which acts as a formidable ceiling due to the concentration of option open interest there. This creates a 'bull trap' risk where buyers get squeezed out before a true breakout occurs. The lack of dividends is irrelevant here; this is a pure growth vehicle betting on the future of genomics. While the long-term trajectory is undeniably upward, the short-term path is likely to be choppy as the market tests whether the $50 level can be breached or if the asset will retreat to find support at the $45 put wall. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.215594 |
| MSTL | 0.223176 |
| AutoETS | 0.226269 |
| AutoARIMA | 0.226270 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 4.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.485 |
| Excess Kurtosis | -0.59 |
As of Oct. 10, 2026, 3:59 a.m. EDT: Speculators are positioning for a volatile range-bound scenario rather than a decisive breakout. Call open interest is heavily concentrated at the $50 strike, creating a dense wall of resistance that suggests traders expect price to struggle to clear this level. Conversely, put open interest is massive at the $45 and $48 strikes, indicating a significant hedge against a drop back toward the lower end of the recent trading range. While there is some volume in out-of-the-money calls ($60-$65), the overwhelming majority of option gamma exposure sits within the $45-$52 band, implying a 'mean reversion' or consolidation thesis rather than a momentum play.
| Date | Dividend | Yield % |
|---|---|---|
| 2021-12-29 | 0.382 | 0.636031 |
| 2020-12-29 | 0.790 | 0.839265 |
| 2019-12-27 | 1.054 | 3.061284 |
| 2018-12-27 | 0.466 | 2.017316 |
| 2017-12-27 | 0.328 | 1.326324 |
| Attribute | Value |
|---|---|
| All Time High | 115.15 |
| All Time Low | 15.001 |
| Ask | 49.8 |
| Ask Size | 400 |
| Average Daily Volume10 Day | 6,260,330 |
| Average Daily Volume3 Month | 4,016,896 |
| Average Volume | 4,016,896 |
| Average Volume10Days | 6,260,330 |
| Beta3 Year | 2.21 |
| Bid | 0.0 |
| Bid Size | 200 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 49.9 |
| Day Low | 46.62 |
| Dividend Yield | 0.0 |
| Esg Populated | 0 |
| Exchange | BTS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 48.664 |
| Fifty Day Average Change | 0.5760002 |
| Fifty Day Average Change Percent | 0.011836269 |
| Fifty Two Week Change Percent | 58.838715 |
| Fifty Two Week High | 58.83 |
| Fifty Two Week High Change | -9.59 |
| Fifty Two Week High Change Percent | -0.16301207 |
| Fifty Two Week Low | 24.6 |
| Fifty Two Week Low Change | 24.640001 |
| Fifty Two Week Low Change Percent | 1.001626 |
| Fifty Two Week Range | 24.6 - 58.83 |
| First Trade Date Milliseconds | 1,414,762,200,000 |
| Five Year Average Return | -0.08420999 |
| Full Exchange Name | Cboe US |
| Fullday Change | 0.37050247 |
| Fullday Change Percent | 0.75244975 |
| Fullday Price | 49.61 |
| Fund Family | ARK ETF Trust |
| Fund Inception Date | 1,414,713,600 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
| Long Name | ARK Genomic Revolution ETF |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_268203657 |
| Nav Price | 48.293 |
| Net Assets | 2,219,066,880.0 |
| Net Expense Ratio | 0.75 |
| Open | 47.33 |
| Phone | 212-426-7040 |
| Pre Market Change | 0.37050247 |
| Pre Market Change Percent | 0.75244975 |
| Pre Market Price | 49.61 |
| Pre Market Time | 1,792,156,740 |
| Previous Close | 48.28 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 0.960003 |
| Regular Market Change Percent | 1.98841 |
| Regular Market Day High | 49.9 |
| Regular Market Day Low | 46.62 |
| Regular Market Day Range | 46.62 - 49.9 |
| Regular Market Open | 47.33 |
| Regular Market Previous Close | 48.28 |
| Regular Market Price | 49.24 |
| Regular Market Time | 1,792,094,400 |
| Regular Market Volume | 7,642,980 |
| Short Name | ARK Genomic Revolution ETF |
| Source Interval | 15 |
| Symbol | ARKG |
| Three Year Average Return | 0.2433189 |
| Total Assets | 2,219,066,880 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 28.92004 |
| Trailing Three Month Returns | 28.92004 |
| Triggerable | 1 |
| Two Hundred Day Average | 36.292126 |
| Two Hundred Day Average Change | 12.947876 |
| Two Hundred Day Average Change Percent | 0.3567682 |
| Type Disp | ETF |
| Volume | 7,642,980 |
| Yield | 0.0 |
| Ytd Return | 87.4905 |